Goldman Urology Clinic announced on the 4th that it has introduced “UROSTONE,” an extracorporeal shock wave lithotripsy system equipped with the latest artificial intelligence (AI) technology.
The device is designed for the treatment of urinary stones and incorporates Korea-patented technologies, including an AI respiratory trigger system and an AI auto-focusing function, which are expected to significantly improve both precision and treatment efficiency.
Conventional shock wave lithotripsy systems often face limitations because the position of a stone can shift slightly with the patient’s breathing. When this occurs, the shock wave may miss the exact target point, reducing the effectiveness of stone fragmentation. In contrast, UROSTONE features a respiration-linked targeting system in which AI analyzes the patient’s breathing pattern in real time and tracks even subtle movements of the stone. The system automatically readjusts the shock wave targeting so that the energy continues to strike the center of the stone, improving fragmentation efficiency and shortening procedure time.
The system also incorporates the only AI-based auto-focusing function in Korea built on advanced image recognition technology. This function automatically analyzes and adjusts the stone’s location and focal point, maximizing the accuracy of the procedure.
A representative from Goldman Urology Clinic explained that the AI system simultaneously detects both the patient’s breathing and the movement of the stone, allowing the device to automatically optimize the delivery of shock waves. As a result, stone fragmentation can be performed more precisely and safely. The clinic expects that the new system will shorten treatment time, reduce patient discomfort and the need for repeat procedures, and ultimately improve patient satisfaction.